Impact Events
More| Date | Lead Company | Event | Type | Approval Change | Approval Likelihood |
|---|---|---|---|---|---|
| 6/5/26 | Zealand Pharma (ZEAL) | petrelintide for Obesity | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/5/26 | Memo Therapeutics | potravitug for Antiviral - Other Treatments | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/26 | ADC Therapeutics (ADCT) | Zynlonta for Diffuse Large B-Cell Lymphoma (DLBCL) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/26 | Roche (RO) | Zelboraf for Colorectal Cancer (CRC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 6/3/26 | Shanghai Kechow Pharma | tunlametinib for Colorectal Cancer (CRC) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
More| Expected Date Range | Lead Company | Drug | Expected Catalyst |
|---|---|---|---|
| 03/31/2023 | Subscribers Only | Subscribers Only | Trial Announcement - Initiation |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/25/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 06/26/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 09/08/2025 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |